Lipid emulsion inhibits vasodilation induced by a toxic dose of bupivacaine by suppressing bupivacaine-induced PKC and CPI-17 dephosphorylation but has no effect on vasodilation induced by a toxic dose of mepivacaine
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The goal of this in vitro study was to investigate the effect of lipid emulsion on vasodilation caused by toxic doses of bupivacaine and mepivacaine during contraction induced by a protein kinase C (PKC) activator, phorbol 12,13-dibutyrate (PDBu), in an isolated endothelium-denuded rat aorta. Methods: The effects of lipid emulsion on the dose-response curves induced by bupivacaine or mepivacaine in an isolated aorta precontracted with PDBu were assessed. In addition, the effects of bupivacaine on the increased intracellular calcium concentration ([Ca2+]i) and contraction induced by PDBu were investigated using fura-2 loaded aortic strips. Further, the effects of bupivacaine, the PKC inhibitor GF109203X and lipid emulsion, alone or in combination, on PDBu-induced PKC and phosphorylation-dependent inhibitory protein of myosin phosphatase (CPI-17) phosphorylation in rat aortic vascular smooth muscle cells (VSMCs) was examined by western blotting. Results: Lipid emulsion attenuated the vasodilation induced by bupivacaine, whereas it had no effect on that induced by mepivacaine. Lipid emulsion had no effect on PDBu-induced contraction. The magnitude of bupivacaine-induced vasodilation was higher than that of the bupivacaine-induced decrease in [Ca2+]i. PDBu promoted PKC and CPI-17 phosphorylation in aortic VSMCs. Bupivacaine and GF109203X attenuated PDBu-induced PKC and CPI-17 phosphorylation, whereas lipid emulsion attenuated bupivacaine-mediated inhibition of PDBu-induced PKC and CPI-17 phosphorylation. Conclusions: These results suggest that lipid emulsion attenuates the vasodilation induced by a toxic dose of bupivacaine via inhibition of bupivacaine-induced PKC and CPI-17 dephosphorylation. This lipid emulsion-mediated inhibition of vasodilation may be partly associated with the lipid solubility of local anesthetics. (Korean J Pain 2016; 29: 229-38)
Abstract
Background: The goal of this in vitro study was to investigate the effect of lipid emulsion on vasodilation caused by toxic doses of bupivacaine and mepivacaine during contraction induced by a protein kinase C (PKC) activator, phorbol 12,13-dibutyrate (PDBu), in an isolated endothelium-denuded rat aorta. Methods: The effects of lipid emulsion on the dose-response curves induced by bupivacaine or mepivacaine in an isolated aorta precontracted with PDBu were assessed. In addition, the effects of bupivacaine on the increased intracellular calcium concentration ([Ca2+]i) and contraction induced by PDBu were investigated using fura-2 loaded aortic strips. Further, the effects of bupivacaine, the PKC inhibitor GF109203X and lipid emulsion, alone or in combination, on PDBu-induced PKC and phosphorylation-dependent inhibitory protein of myosin phosphatase (CPI-17) phosphorylation in rat aortic vascular smooth muscle cells (VSMCs) was examined by western blotting. Results: Lipid emulsion attenuated the vasodilation induced by bupivacaine, whereas it had no effect on that induced by mepivacaine. Lipid emulsion had no effect on PDBu-induced contraction. The magnitude of bupivacaine-induced vasodilation was higher than that of the bupivacaine-induced decrease in [Ca2+]i. PDBu promoted PKC and CPI-17 phosphorylation in aortic VSMCs. Bupivacaine and GF109203X attenuated PDBu-induced PKC and CPI-17 phosphorylation, whereas lipid emulsion attenuated bupivacaine-mediated inhibition of PDBu-induced PKC and CPI-17 phosphorylation. Conclusions: These results suggest that lipid emulsion attenuates the vasodilation induced by a toxic dose of bupivacaine via inhibition of bupivacaine-induced PKC and CPI-17 dephosphorylation. This lipid emulsion-mediated inhibition of vasodilation may be partly associated with the lipid solubility of local anesthetics. (Korean J Pain 2016; 29: 229-38)
참고문헌 (34)
- Weinberg GL, "Lipid emulsion infusion: resuscitation for local anesthetic and other drug overdose", Anesthesiology, 117, pp.180~187 (2012)
- Cao D, "Intravenous lipid emulsion in the emergency department : a systematic review of recent literature", J Emerg Med, 48, pp.387~397 (2015)
- 옥성호, "Lipid emulsion-mediated reversal of toxic-dose aminoamide local anesthetic-induced vasodilation in isolated rat aorta", Korean Journal of Anesthesiology, 64(4), pp.353~359 (2013), 대한마취통증의학회
- Ok SH, "Ropivacaine-induced contraction is attenuated by both endothelial nitric oxide and voltage-dependent potassium channels in isolated rat aortae", Biomed Res Int, 2013, pp.565271~ (2013)
- 옥성호, "Mepivacaine-induced intracellular calcium increase appears to be mediated primarily by calcium influx in rat aorta without endothelium", Korean Journal of Anesthesiology, 67(6), pp.404~411 (2014), 대한마취통증의학회
- Baik JS, "Levobupivacaine-induced contraction of isolated rat aorta is calcium dependent", Can J Physiol Pharmacol, 89, pp.467~476 (2011)
- Ok SH, "Lipid emulsion reverses Levobupivacaine-induced responses in isolated rat aortic vessels", Anesthesiology, 114, pp.293~301 (2011)
- Mulroy MF, "Systemic toxicity and cardiotoxicity from local anesthetics : incidence and preventive measures", Reg Anesth Pain Med, 27, pp.556~561 (2002)
- Akata T, "General anesthetics and vascular smooth muscle : direct actions of general anesthetics on cellular mechanisms regulating vascular tone", Anesthesiology, 106, pp.365~391 (2007)
- 옥성호, "Bupivacaine-induced Vasodilation Is Mediated by Decreased Calcium Sensitization in Isolated Endothelium-denuded Rat Aortas Precontracted with Phenylephrine", The Korean Journal of Pain, 27(3), pp.229~238 (2014), 대한통증학회
- Akata T, "Cellular and molecular mechanisms regulating vascular tone. Part 1: basic mechanisms controlling cytosolic Ca2+ concentration and the Ca2+-dependent regulation of vascular tone", J Anesth, 21, pp.220~231 (2007)
- Ok SH, "Lipid emulsion inhibits vasodilation induced by a toxic dose of bupivacaine via attenuated dephosphorylation of myosin phosphatase target subunit 1 in isolated rat aorta", Int J Med Sci, 12, pp.958~967 (2015)
- Sung HJ, "Mepivacaine-induced contraction is attenuated by endothelial nitric oxide release in isolated rat aorta", Can J Physiol Pharmacol, 90, pp.863~872 (2012)
- Lee HM, "Mepivacaine-induced contraction involves phosphorylation of extracellular signal-regulated kinase through activation of the lipoxygenase pathway in isolated rat aortic smooth muscle", Can J Physiol Pharmacol, 91, pp.285~294 (2013)
- Karaki H, "Ca2+ localization and sensitivity in vascular smooth muscle", Trends Pharmacol Sci, 10, pp.320~325 (1989)
- Somlyo AP, "Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II", J Physiol, 522, pp.177~185 (2000)
- Fukata Y, "Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells", Trends Pharmacol Sci, 22, pp.32~39 (2001)
- Kitazawa T, "Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility", J Biol Chem, 275, pp.9897~9900 (2000)
- Koyama M, "Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase", FEBS Lett, 475, pp.197~200 (2000)
- Partownavid P, "Fatty-acid oxidation and calcium homeostasis are involved in the rescue of bupivacaine-induced cardiotoxicity by lipid emulsion in rats", Crit Care Med, 40, pp.2431~2437 (2012)
- Fettiplace MR, "Rapid cardiotonic effects of lipid emulsion infusion", Crit Care Med, 41, pp.e156~e162 (2013)
- Fettiplace MR, "Multi-modal contributions to detoxification of acute pharmacotoxicity by a triglyceride micro-emulsion", J Control Release, 198, pp.62~70 (2015)
- 이수희, "Lipid Emulsions Enhance the Norepinephrine-Mediated Reversal of Local Anesthetic-Induced Vasodilation at Toxic Doses", Yonsei Medical Journal, 54(6), pp.1524~1532 (2013), 연세대학교의과대학[DOI]
- Ok SH, "Lipid emulsion attenuates apoptosis induced by a toxic dose of bupivacaine in H9c2 rat cardiomyoblast cells", Hum Exp Toxicol, 35, pp.929~937 (2016)
- Aumeier C, "Lipid emulsion pretreatment has different effects on mepivacaine and bupivacaine cardiac toxicity in an isolated rat heart model", Br J Anaesth, 112, pp.735~741 (2014)
- Zausig YA, "Lipid emulsion improves recovery from bupivacaineinduced cardiac arrest, but not from ropivacaine- or mepivacaine-induced cardiac arrest", Anesth Analg, 109, pp.1323~1326 (2009)
- McLure HA, "Review of local anaesthetic agents", Minerva Anestesiol, 71, pp.59~74 (2005)
- 신일우, "LipofundinⓇ MCT", LCT 20% increase left ventricular systolic pressure in an ex vivo rat heart model via increase of intracellular calcium level, 2016, pp.69(1), 57~62[DOI]
- Ward JP, "Protein kinases in vascular smooth muscle tone--role in the pulmonary vasculature and hypoxic pulmonary vasoconstriction", Pharmacol Ther, 104, pp.207~231 (2004)
- Neal JM, "ASRA practice advisory on local anesthetic systemic toxicity", Reg Anesth Pain Med, 35, pp.152~161 (2010)
- Lee JH, "Respiratory arrest during epidural infusion of bupivacaine and morphine", J Korean Pain Soc, 8, pp.386~389 (1995)
- Santos AC, "Systemic toxicity of levobupivacaine, bupivacaine, and ropivacaine during continuous intravenous infusion to nonpregnant and pregnant ewes", Anesthesiology, 95, pp.1256~1264 (2001)
- Shin IW, "Systemic blockage of nitric oxide synthase by L-NAME increases left ventricular systolic pressure, which is not augmented further by IntralipidⓇ", Int J Biol Sci, 10, pp.367~376 (2014)
- Christensen KL, "Location of resistance arteries", J Vasc Res, 38, pp.1~12 (2001)
